Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

NCT03497273 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03497273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03497273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Completed
Start date
March 20, 2018
Completion date
February 17, 2020
Enrollment
14 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft-versus-host disease